{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T20:53:35Z","timestamp":1761512015201},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[1992,3,1]],"date-time":"1992-03-01T00:00:00Z","timestamp":699408000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Chemother. Pharmacol."],"published-print":{"date-parts":[[1992,3]]},"DOI":"10.1007\/bf00685104","type":"journal-article","created":{"date-parts":[[2004,11,28]],"date-time":"2004-11-28T14:40:01Z","timestamp":1101652801000},"page":"156-160","source":"Crossref","is-referenced-by-count":15,"title":["Analysis and pharmacokinetics ofN-l-leucyldoxorubicin and metabolites in tissues of tumor-bearing BALB\/c mice"],"prefix":"10.1007","volume":"31","author":[{"given":"Jan","family":"de Jong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ina","family":"Klein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aalt","family":"Bast","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wim J. F.","family":"van der Vijgh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/0277-5379(86)90112-4","volume":"22","author":"J Cummings","year":"1986","unstructured":"Cummings J, Merry S, Willmott N (1986) Disposition kinetics of Adriamycin, Adriamycinol and their 7-deoxyaglycones in AKR mice bearing subcutaneously growing Ridgeway osteogenic sarcoma (ROS). Eur J Cancer Clin Oncol 22: 451","journal-title":"Eur J Cancer Clin Oncol"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0378-4347(00)83842-6","volume":"529","author":"J Jong De","year":"1990","unstructured":"De Jong J, Maessen PA, Akkerdaas A, Cheung S-F, Pinedo HM, Van der Vijgh WJF (1990) A sensitive method for the determination of daunorubicin and all its known metabolites in plasma and heart by high-performance liquid chromatography with fluorescence detection. J Chromatogr 529: 359","journal-title":"J Chromatogr"},{"key":"CR3","first-page":"1567","volume":"33","author":"J Jong De","year":"1992","unstructured":"De Jong J, Geijssen GJ, Wolbink G-J, Vermorken JB, Van der Vijgh WJF (1992) Phase I study ofN-l-leucyldoxorubicin. Final report regarding pharmacokinetics and pharmacodynamics. Proc Am Assoc Cancer Res 33: 1567","journal-title":"Proc Am Assoc Cancer Res"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/0378-4347(92)80040-W","volume":"574","author":"J Jong De","year":"1992","unstructured":"De Jong J, Munniksma CN, Gu\u00e9rand WS, Bast A, Van der Vijgh WJF (1992) Fully automated determination of a new anthracycline,N-l-leucyldoxorubicin, and its six known metabolites in plasma by high-performance liquid chromatography with on-line sample handling. J Chromatogr 574: 273","journal-title":"J Chromatogr"},{"key":"CR5","doi-asserted-by":"crossref","unstructured":"De Jong J, Geijssen GJ, Munniksma CN, Vermorken JB, Van der Vijgh WJF (1992) Plasma pharmacokinetics and pharmacodynamics of a new prodrug N-l-leucyldoxorubicin and its metabolites in a Phase I clinical trial. J Clin Oncol (in press)","DOI":"10.1200\/JCO.1992.10.12.1897"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/BF00255483","volume":"8","author":"D Deprez-de Campeneere","year":"1982","unstructured":"Deprez-de Campeneere D, Baurain R, Trouet A (1982) Accumulation and metabolism of new anthracycline derivatives in the heart after i.v injection into mice. Cancer Chemother Pharmacol 8: 193","journal-title":"Cancer Chemother Pharmacol"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0378-5173(87)90133-5","volume":"35","author":"JG Dubois","year":"1987","unstructured":"Dubois JG, Hanocq M, Atassi G (1987) Extraction and assay of daunorubicin and metabolites from neoplastic tissue. Int J Pharm 35: 219","journal-title":"Int J Pharm"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1201\/b14095","volume-title":"Pharmacokinetics","author":"M Gibaldi","year":"1982","unstructured":"Gibaldi M, Perrier D (1982) Pharmacokinetics, 2nd edn. Marcel Dekker, New York, p 409","edition":"2nd edn."},{"key":"CR9","first-page":"3530","volume":"40","author":"RS Jaenke","year":"1980","unstructured":"Jaenke RS, Deprez-DeCampeneere D, Trouet A (1980) Cardiotoxicity and comparative pharmacokinetics of six anthracyclines. Cancer Res 40: 3530","journal-title":"Cancer Res"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0378-4347(00)81080-4","volume":"424","author":"PA Maessen","year":"1988","unstructured":"Maessen PA, Pinedo HM, Mross K, Van der Vijgh WJF (1988) A new method for the determination of doxorubicin, 4?-epidoxorubicin and all known metabolites in tissue. J Chromatogr 424: 103","journal-title":"J Chromatogr"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1021\/jm00185a003","volume":"23","author":"M Masquelier","year":"1980","unstructured":"Masquelier M, Baurain R, Trouet A (1980) Amino acid and dipeptide derivatives of daunorubicin: I. Synthesis, physicochemical properties, and lysosomal digestion. J Med Chem 23: 1166","journal-title":"J Med Chem"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1200\/JCO.1988.6.3.517","volume":"6","author":"K Mross","year":"1988","unstructured":"Mross K, Maessen PA, Van der Vijgh WJF, Gall H, Boven E, Pinedo HM (1988) Pharmacokinetics and metabolism of epirubicin and doxorubicin in humans. J Clin Oncol 6: 517","journal-title":"J Clin Oncol"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"3585","DOI":"10.1073\/pnas.85.10.3585","volume":"85","author":"RD Olson","year":"1988","unstructured":"Olson RD, Mushlin PS, Brenner DE, Fleischer S, Cusack BJ, Chang BK, Bousek RJ (1988) Doxorubicin cardiotoxicity may be caused by its metabolite, doxorubicinol. Proc Natl Acad Sci USA 85: 3585","journal-title":"Proc Natl Acad Sci USA"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S0021-9673(00)84748-2","volume":"196","author":"S Shinozawa","year":"1980","unstructured":"Shinozawa S, Mimaki Y, Araki Y, Oda T (1980) Determination of the concentration of Adriamycin and its metabolites in the serum and tissues of Ehrlich carcinoma-bearing mice by high-performance liquid chromatography. J Chromatogr 196: 463","journal-title":"J Chromatogr"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/BF02940286","volume":"26","author":"WJF Vijgh Van der","year":"1990","unstructured":"Van der Vijgh WJF, Maessen PA, Pinedo HM (1990) Comparative metabolism and pharmacokinetics of doxorubicin and 4?-epidoxorubicin in plasma, heart and tumor of tumor-bearing mice. Cancer Chemother Pharmacol 26: 9","journal-title":"Cancer Chemother Pharmacol"}],"container-title":["Cancer Chemotherapy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00685104.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00685104\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00685104","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,29]],"date-time":"2021-06-29T23:23:42Z","timestamp":1625009022000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00685104"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1992,3]]},"references-count":15,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1992,3]]}},"alternative-id":["BF00685104"],"URL":"https:\/\/doi.org\/10.1007\/bf00685104","relation":{},"ISSN":["0344-5704","1432-0843"],"issn-type":[{"value":"0344-5704","type":"print"},{"value":"1432-0843","type":"electronic"}],"subject":[],"published":{"date-parts":[[1992,3]]}}}